FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Mark Smolkin

Research Profile

Chemicals & Drugs

Disorders

Concepts & Ideas

Anatomy

Procedures

Mammography

Living Beings

Mouse

Co-author Network

Publications

TOP 3
Amber L Shada; Scott Acton; Lynn T Dengel; Gina R Petroni; Mark E Smolkin; Craig L Slingluff
Infrared thermography of cutaneous melanoma metastases.
Lauren E Giugale; Laura Havrilesky; Nicola Di Santo; Mark E Smolkin; Susan C Modesitt
Beyond mere obesity: effect of increasing obesity classifications on hysterectomy outcomes for uterine cancer/hyperplasia.
Susannah E McClain; James W Patterson; Amber L Shada; Kira B Mayo; Mark E Smolkin; Craig L Slingluff
Amelanotic melanomas presenting as red skin lesions: a diagnostic challenge with potentially lethal consequences.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Mark Smolkin (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Amber L Shada; Scott Acton; Lynn T Dengel; Gina R Petroni; Mark E Smolkin; Craig L Slingluff
Infrared thermography of cutaneous melanoma metastases.
The Journal of surgical research 2013;182(1):e9-e14.
2012: Lauren E Giugale; Laura Havrilesky; Nicola Di Santo; Mark E Smolkin; Susan C Modesitt
Beyond mere obesity: effect of increasing obesity classifications on hysterectomy outcomes for uterine cancer/hyperplasia.
Gynecologic oncology 2012;127(2):326-31.
2012: Susannah E McClain; James W Patterson; Amber L Shada; Kira B Mayo; Mark E Smolkin; Craig L Slingluff
Amelanotic melanomas presenting as red skin lesions: a diagnostic challenge with potentially lethal consequences.
International journal of dermatology 2012;51(4):420-6.
2012: Gulsun Erdag; James W Patterson; Jochen T Schaefer; Sofia M Shea; Donna H Deacon; Lynn T Dengel; Mark E Smolkin; Craig L Slingluff
Immunotype and immunohistologic characteristics of tumor-infiltrating immune cells are associated with clinical outcome in metastatic melanoma.
Cancer research 2012;72(5):1070-80.
2011: Craig L Slingluff; Mark E Smolkin; Margaret von Mehren; Kimberly A Chianese-Bullock; Naomi B Haas; Gina R Petroni; Merrick I Ross; William W Grosh
Randomized multicenter trial of the effects of melanoma-associated helper peptides and cyclophosphamide on the immunogenicity of a multipeptide melanoma vaccine.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(21):2924-32.
2011: Walter C Olson; Mark E Smolkin; Erin M Farris; Robyn J Fink; Andrea R Czarkowski; Jonathan H Fink; Kimberly A Chianese-Bullock; Craig L Slingluff
Shipping blood to a central laboratory in multicenter clinical trials: effect of ambient temperature on specimen temperature, and effects of temperature on mononuclear cell yield, viability and immunologic function.
Journal of translational medicine 2011;9():26.
2010: Craig L Slingluff; Gina R Petroni; Mark E Smolkin; Kimberly A Chianese-Bullock; Kelly Smith; Cheryl Murphy; Nadedja Galeassi; Patrice Y Neese; William W Grosh; Carmel J Nail; Merrick Ross; Margaret von Mehren; Naomi Haas; Marc E Boisvert; John M Kirkwood
Immunogenicity for CD8+ and CD4+ T cells of 2 formulations of an incomplete freund's adjuvant for multipeptide melanoma vaccines.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2010;33(6):630-8.
2010: Helen P Cathro; Mark E Smolkin; Dan Theodorescu; Vickie Y Jo; Soldano Ferrone; Henry F Frierson
Relationship between HLA class I antigen processing machinery component expression and the clinicopathologic characteristics of bladder carcinomas.
Cancer immunology, immunotherapy : CII 2010;59(3):465-72.
2010: Jochen T Schaefer; James W Patterson; Donna H Deacon; Mark E Smolkin; Gina R Petroni; Emily M Jackson; Craig L Slingluff
Dynamic changes in cellular infiltrates with repeated cutaneous vaccination: a histologic and immunophenotypic analysis.
Journal of translational medicine 2010;8():79.
2009: Craig L Slingluff; Gina R Petroni; Walter C Olson; Mark E Smolkin; Merrick I Ross; Naomi B Haas; William W Grosh; Marc E Boisvert; John M Kirkwood; Kimberly A Chianese-Bullock
Effect of granulocyte/macrophage colony-stimulating factor on circulating CD8+ and CD4+ T-cell responses to a multipeptide melanoma vaccine: outcome of a multicenter randomized trial.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(22):7036-44.
2009: Steven Christopher Smith; Brian Nicholson; Matthew Nitz; Henry F Frierson; Mark E Smolkin; Garret M Hampton; Wa'el El-Rifai; Dan Theodorescu
Profiling bladder cancer organ site-specific metastasis identifies LAMC2 as a novel biomarker of hematogenous dissemination.
The American journal of pathology 2009;174(2):371-9.
2008: Lisa M Sullivan; Mark E Smolkin; Henry F Frierson; Mary T Galgano
Comprehensive evaluation of CDX2 in invasive cervical adenocarcinomas: immunopositivity in the absence of overt colorectal morphology.
The American journal of surgical pathology 2008;32(11):1608-12.
2008: Craig L Slingluff; Gina R Petroni; Walter Olson; Andrea Czarkowski; William W Grosh; Mark E Smolkin; Kimberly A Chianese-Bullock; Patrice Y Neese; Donna H Deacon; Carmel Nail; Priscilla Merrill; Robyn Fink; James W Patterson; Patrice K Rehm
Helper T-cell responses and clinical activity of a melanoma vaccine with multiple peptides from MAGE and melanocytic differentiation antigens.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(30):4973-80.
2008: Kimberly A Chianese-Bullock; William P Irvin; Gina R Petroni; Cheryl Murphy; Mark E Smolkin; Walter C Olson; Elizabeth Coleman; Scott A Boerner; Carmel J Nail; Patrice Y Neese; Arlene Yuan; Kevin T Hogan; Craig L Slingluff
A multipeptide vaccine is safe and elicits T-cell responses in participants with advanced stage ovarian cancer.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2008;31(4):420-30.
2008: Jennifer A Harvey; Richard J Santen; Gina R Petroni; Viktor E Bovbjerg; Mark E Smolkin; Fathima S Sheriff; Jose Russo
Histologic changes in the breast with menopausal hormone therapy use: correlation with breast density, estrogen receptor, progesterone receptor, and proliferation indices.
Menopause (New York, N.Y.) 2008;15(1):67-73.
2007: Craig L Slingluff; Gina R Petroni; Kimberly A Chianese-Bullock; Mark E Smolkin; Sarah Hibbitts; Cheryl Murphy; Naomi Johansen; William W Grosh; Galina V Yamshchikov; Patrice Y Neese; James W Patterson; Robyn Fink; Patrice K Rehm
Immunologic and clinical outcomes of a randomized phase II trial of two multipeptide vaccines for melanoma in the adjuvant setting.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(21):6386-95.
2007: Sarah C Flury; Mary T Galgano; Stacey E Mills; Mark E Smolkin; Dan Theodorescu
Atypical small acinar proliferation: biopsy artefact or distinct pathological entity?
BJU international 2007;99(4):780-5.
2006: Sophie G Fletcher; Stacey E Mills; Mark E Smolkin; Dan Theodorescu
Case-matched comparison of contemporary radiation therapy to surgery in patients with locally advanced prostate cancer.
International journal of radiation oncology, biology, physics 2006;66(4):1092-9.
2006: Jonathan J Rhee; Sam Lebeau; Mark E Smolkin; Dan Theodorescu
Radical cystectomy with ileal conduit diversion: early prospective evaluation of the impact of robotic assistance.
BJU international 2006;98(5):1059-63.
2006: Brandi T Nicholson; Alexander P LoRusso; Mark E Smolkin; Viktor E Bovbjerg; Gina R Petroni; Jennifer A Harvey
Accuracy of assigned BI-RADS breast density category definitions.
Academic radiology 2006;13(9):1143-9.
2006: David R Jones; Thomas M Daniel; Chadrick E Denlinger; Brian K Rundall; Mark E Smolkin; Mark Wick
Stage IB nonsmall cell lung cancers: are they all the same?
The Annals of thoracic surgery 2006;81(6):1958-62; discussion 1962.
2006: Craig L Slingluff; Kimberly A Chianese-Bullock; Timothy N J Bullock; William W Grosh; David W Mullins; Lisa Nichols; Walter Olson; Gina R Petroni; Mark E Smolkin; Victor H Engelhard
Immunity to melanoma antigens: from self-tolerance to immunotherapy.
Advances in immunology 2006;90():243-95.
2005: William Chad Cragun; Galina V Yamshchikov; Eric A Bissonette; Mark E Smolkin; Shannon Eastham; Gina R Petroni; Randy S Schrecengost; Elizabeth M H Woodson; Craig L Slingluff
Low-dose IL-2 induces cytokine cascade, eosinophilia, and a transient Th2 shift in melanoma patients.
Cancer immunology, immunotherapy : CII 2005;54(11):1095-105.
2005: Jennifer A Harvey; Viktor E Bovbjerg; Mark E Smolkin; Mark B Williams; Gina R Petroni
Evaluating hormone therapy-associated increases in breast density comparison between reported and simultaneous assignment of BI-RADS categories, visual assessment, and quantitative analysis.
Academic radiology 2005;12(7):853-62.
2005: Kimberly A Chianese-Bullock; Elizabeth M H Woodson; Huimin Tao; Scott A Boerner; Mark E Smolkin; William W Grosh; Patrice Y Neese; Priscilla Merrill; Gina R Petroni; Craig L Slingluff
Autoimmune toxicities associated with the administration of antitumor vaccines and low-dose interleukin-2.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2005;28(4):412-9.
2005: Nicole Miller; Mark E Smolkin; Eric A Bissonette; Dan Theodorescu
Undetectable prostate specific antigen at 6-12 months: a new marker for early success in hormonally treated patients after prostate brachytherapy.
Cancer 2005;103(12):2499-506.
2005: C E Long; James A Blackman; Walter J Farrell; Mark E Smolkin; Mark Conaway
A comparison of developmental versus functional assessment in the rehabilitation of young children.
Pediatric rehabilitation 2005;8(2):156-61.
2004: Teresa A Urban; Adam Griffith; Anastasia M Torok; Mark E Smolkin; Jane L Burns; Joanna B Goldberg
Contribution of Burkholderia cenocepacia flagella to infectivity and inflammation.
Infection and immunity 2004;72(9):5126-34.
2004: Amy J French; Gina R Petroni; Stephen N Thibideau; Mark E Smolkin; Eric A Bissonette; Franco Roviello; Jeffrey C Harper; Benjamin R Koch; Sarah A Anderson; Scott J Hebbring; Steven M Powell
Allelic imbalance of 8p indicates poor survival in gastric cancer.
The Journal of molecular diagnostics : JMD 2004;6(3):243-52.
2004: Tomas Vomastek; Hans-Joerg Schaeffer; Adel Tarcsafalvi; Mark E Smolkin; Eric A Bissonette; Michael J Weber
Modular construction of a signaling scaffold: MORG1 interacts with components of the ERK cascade and links ERK signaling to specific agonists.
Proceedings of the National Academy of Sciences of the United States of America 2004;101(18):6981-6.
2004: Natalie Koon; R Schneider-Stock; Maarit Sarlomo-Rikala; J Lasota; Mark E Smolkin; Gina R Petroni; Alexander Zaika; C Boltze; F Meyer; L Andersson; Sakari Knuutila; M Miettinen; Wa'el El-Rifai
Molecular targets for tumour progression in gastrointestinal stromal tumours.
Gut 2004;53(2):235-40.